Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 3/20 | 0.65 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.65 |
| ▸ | SPHK1 | Q9NYA1 | 2/20 | 0.65 |
| ▸ | GMNN | O75496 | 1/20 | 0.65 |
| ▸ | POLB | P06746 | 1/20 | 0.65 |
| ▸ | THPO | P40225 | 1/20 | 0.65 |
| ▸ | MTOR | P42345 | 1/20 | 0.65 |
| ▸ | BLM | P54132 | 1/20 | 0.65 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.65 |
| ▸ | TP53 | P04637 | 1/20 | 0.65 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.65 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.65 |
| ▸ | MAPT | P10636 | 1/20 | 0.65 |
| ▸ | CETP | P11597 | 1/20 | 0.65 |
| ▸ | HTT | P42858 | 1/20 | 0.65 |
| ▸ | UBE2N | P61088 | 1/20 | 0.65 |
| ▸ | MEN1 | O00255 | 1/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.50 |
| ▸ | ASAH1 | Q13510 | 1/20 | 0.49 |
| ▸ | GPR84 | Q9NQS5 | 3/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL313926 | 1.00 | LMNA (0.65) | LMNACYP2D6SPHK1GMNNPOLB | |
| SCHEMBL932976 | 1.00 | LMNA (0.65) | LMNACYP2D6SPHK1GMNNPOLB | |
| Hexane SCHEMBL17093132 | 1.00 | LMNA (0.65) | LMNACYP2D6SPHK1GMNNPOLB | |
| SCHEMBL10563903 | 1.00 | LMNA (0.65) | LMNACYP2D6SPHK1GMNNPOLB | |
| SCHEMBL7063457 | 1.00 | LMNA (0.65) | LMNACYP2D6SPHK1GMNNPOLB | |
| SCHEMBL15013420 | 1.00 | LMNA (0.65) | LMNACYP2D6SPHK1GMNNPOLB | |
| SCHEMBL25243382 | 1.00 | LMNA (0.65) | LMNACYP2D6SPHK1GMNNPOLB | |
| SCHEMBL440182 | 1.00 | LMNA (0.65) | LMNACYP2D6SPHK1GMNNPOLB | |
| SCHEMBL118392 | 1.00 | LMNA (0.65) | LMNACYP2D6SPHK1GMNNPOLB | |
| SCHEMBL10571108 | 1.00 | LMNA (0.65) | LMNACYP2D6SPHK1GMNNPOLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 211 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260042972-A1 | MIXED COMPONENT TRACTION FLUIDS | VANTAGE SANTOLUBES RES LLC (US) | 2026-02-12 | — | — | US | claimed |
| CN-116173041-A | Progesterone composition, preparation method thereof and progesterone microneedle transdermal patch | 广州鹏兴医药科技有限公司 | 2023-05-30 | — | — | CN | claimed |
| US-20220402833-A1 | Nutritional Compositions for Plants and Soils | ENVIROKURE, INCORPORATED (US) | 2022-12-22 | — | — | US | claimed |
| CN-107106663-B | Compositions and kits for enzymatic debridement and methods of use thereof | 罗查尔科技有限责任公司 | 2022-12-06 | — | — | CN | claimed |
| CN-115154595-A | Preparation method of nano-structure lipid carrier adjuvant and veterinary vaccine | 国药集团动物保健股份有限公司 | 2022-10-11 | — | — | CN | claimed |
| US-10260071-B2 | CpG oligonucleotide analogs containing hydrophobic T analogs with enhanced immunostimulatory activity | COLEY PHARMACEUTICAL GMBH (DE) | 2019-04-16 | — | — | US | claimed |
| CN-107106663-A | Composition and kit and its application method for enzyme debridement | 罗查尔工业有限责任公司 | 2017-08-29 | — | — | CN | claimed |
| CN-106687100-A | Cosmetic compositions and methods for inhibiting melanin synthesis | 宝洁公司 | 2017-05-17 | — | — | CN | claimed |
| US-20160348115-A1 | CpG Oligonucleotide Analogs Containing Hydrophobic T Analogs with Enhanced Immunostimulatory Activity | PFIZER INC. | 2016-12-01 | — | — | US | claimed |
| CN-104910016-A | Preparation method and application of stearylglycerol in Lycium ruthenicum Murr | NORTHWEST INST PLATEAU BIO CAS | 2015-09-16 | — | — | CN | claimed |
| US-20080255015-A1 | COMPOSITION BASED ON GLYCEROL ETHER/POLYOL MIXTURES | AIR LIQUIDE SANTE (INTERNATIONAL) (FR) | 2008-10-16 | — | — | US | claimed |
| WO-2008068638-A2 | CPG OLIGONUCLEOTIDE ANALOGS CONTAINING HYDROPHOBIC T ANALOGS WITH ENHANCED IMMUNOSTIMULATORY ACTIVITY | COLEY PHARMACEUTICAL GMBH (DE) | 2008-06-12 | — | — | WO | claimed |
| CN-1330682-C | Composition for using polywax with biological absorptivity and medical device | ETHICON INC (US) | 2007-08-08 | — | — | CN | claimed |
| CN-1302041-C | Cationic alkgd polyester capable for medical application | ETHICON INC (US) | 2007-02-28 | — | — | CN | claimed |
| CN-1524903-A | Crosslinked alkyd polyesters for medical applications | 伊西康公司 | 2004-09-01 | — | — | CN | claimed |
| CN-1517380-A | Composition for using polywax with biological absorptivity and medical device | — | 2004-08-04 | — | — | CN | claimed |
| CN-1513894-A | Cationic alkgd polyester capable for medical application | — | 2004-07-21 | — | — | CN | claimed |
| CN-1471907-A | Particle for releasing polymer coating | — | 2004-02-04 | — | — | CN | claimed |
| CN-1072593-A | The surfactant and the using method that contain alkyl phosphorylcholine or alkyl glycerol Phosphorylcholine | HEMAGEN PFC (US) | 1993-06-02 | — | — | CN | claimed |
| EP-0100826-B1 | ACRYLIC FIBERS FOR PRODUCING CARBON FIBERS | TORAY INDUSTRIES, INC. (JP) | 1989-05-03 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080255015-A1 | COMPOSITION BASED ON GLYCEROL ETHER/POLYOL MIXTURES | MGLL, DAGLA, DAGLB | LMNA 2341/4885CYP2D6 1929/4885SPHK1 83/4885 |
| US-20260042972-A1 | MIXED COMPONENT TRACTION FLUIDS | CFD, VCL, ANXA2 | LMNA 904/4885CYP2D6 4161/4885SPHK1 3366/4885 |
| US-10260071-B2 | CpG oligonucleotide analogs containing hydrophobic T analogs with enhanced immunostimulatory activity | TLR9, TYMP, STING1 | LMNA 4419/4885CYP2D6 3105/4885SPHK1 2011/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.